T2 Biosystems, Inc.

TTOO · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$50-$62-$49-$47
Dep. & Amort.$1$2$3$3
Deferred Tax$0$0-$1-$0
Stock-Based Comp.$4$6$7$4
Change in WC-$4-$1-$2-$7
Other Non-Cash$1$3$4$3
Operating Cash Flow-$48-$51-$39-$43
Investing Activities
PP&E Inv.-$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$51
Inv. Sales/Matur.$0$10$25$15
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$10$25-$36
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$53$30$20$85
Stock Repurch.$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0$1$0
Financing Cash Flow$53$29$21$86
Forex Effect$0$0$0$0
Net Chg. in Cash$4-$12$6$6
Supplemental Information
Beg. Cash$12$24$17$11
End Cash$16$12$24$17
Free Cash Flow-$48-$51-$39-$44